## **Core Concept**
The question tests knowledge of antiretroviral therapy side effects, specifically bone marrow suppression. Antiretroviral drugs are used to treat HIV infection and can have various side effects, including effects on the bone marrow. Bone marrow suppression can lead to decreased production of blood cells, resulting in conditions like anemia, neutropenia, and thrombocytopenia.

## **Why the Correct Answer is Right**
Zidovudine (AZT) is a nucleoside reverse transcriptase inhibitor (NRTI) used in the treatment of HIV/AIDS. One of its well-known side effects is bone marrow suppression, which can manifest as anemia and neutropenia. This side effect is significant enough to warrant regular monitoring of blood counts in patients on this medication.

## **Why Each Wrong Option is Incorrect**
- **Option A:** Lamivudine is also an NRTI but is not as commonly associated with bone marrow suppression as Zidovudine. While it can cause side effects, bone marrow suppression is less frequently highlighted as a major concern.
- **Option B:** Efavirenz is a non-nucleoside reverse transcriptase inhibitor (NNRTI). It is not commonly associated with bone marrow suppression. Its side effects more often include neurological and psychiatric symptoms.
- **Option C:** This option seems to be a placeholder and does not directly correspond to a commonly recognized antiretroviral drug in the provided text.

## **Clinical Pearl / High-Yield Fact**
A key point to remember is that Zidovudine (AZT) is notably associated with bone marrow suppression, a side effect that can necessitate dose adjustment or switching to an alternative antiretroviral regimen. This association is critical for managing patients on antiretroviral therapy.

## **Correct Answer:** D. Zidovudine.